Board of Directors (2020)

The Board of Directors is the legally and financially responsible body that sets the strategic direction of TOPRA and makes sure that all is running smoothly. Board elections are held annually for Officers and every two years for Directors. Any member, wherever they live or whatever their regulatory experience, can stand for election.

The members of the Board as of 9 January 2020 are:


Office Term Name Professional position 
President 1 year

Stephen Hayes  

Associate Director, Regulatory Development
Norgine, UK
Past-President 1 year

Nick Sykes

Director, European Regulatory Policy and Director, Regulatory Policy & Intelligence
Pfizer, UK
President-Elect 1 year

Anne Nallen

Associate Director, Regulatory Affairs
Zoetis Belgium SA, Ireland


Directors with special geographic responsibilities *

Office Term  Name  Professional position
North America 2 years Natalie Tolli Vice President, Regulatory Affairs (Regulatory International, Regulatory Policy & Intelligence)
AbbVie, USA 
Europe 2 years Eva Kopecna  Head of Regulatory Affairs
Zentiva, Switzerland 

* In second year of their term in 2020

Directors without portfolio **

Office Term Name Professional position
Director 2 yrs Janine Jamieson Founder and consultant, JCombinations AB; and EU Editor at IPQ Publications, Sweden
Director 2 yrs Aine Kane Associate Research Fellow (Regulatory CMC)
Director  2 yrs Evgenia Mengou Director
EV Pharma Solutions, UK
 Director 2 yrs Fiona Reekie Founder and Principal, Pintells Pharma Consulting; and Senior Director, Head of Global Regulatory Policy and Intelligence, Global Regulatory Affairs, UCB, UK

** In first year of their term in 2020

Angela StokesBeing a member of the Board has given me insights into the running of a boardroom, I have been given an opportunity to shape the future of OUR professional organisation and I have met and worked with a great bunch of people.”

Angela Stokes
TOPRA President 2018